All requests are reviewed by qualified healthcare professionals.
- Email: support@novametabolic.com
- Phone: 555
-
English
English
Metabolic Health
Ozempic® (semaglutide) is a prescription GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes mellitus. It is used alongside diet and exercise to help manage glucose levels and support overall metabolic health. Ozempic is administered as a once-weekly subcutaneous injection, offering a convenient dosing option for long-term diabetes management.
Ozempic® (semaglutide) is a prescription GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes mellitus. It is used alongside diet and exercise to help manage glucose levels and support overall metabolic health.
Ozempic is administered as a once-weekly subcutaneous injection, offering a convenient dosing option for long-term diabetes management.
Ozempic mimics the natural hormone GLP-1, which helps regulate blood sugar by:
Ozempic is not insulin and is not used for type 1 diabetes. It should be used as part of a comprehensive diabetes management plan under medical supervision.
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite, especially during dose initiation.
| Starting Dose | 0.25mg once weekly (weeks 1-4) |
|---|---|
| Maintenance Dose | 0.5mg once weekly |
| Maximum Dose | 1mg once weekly |
| Administration | Subcutaneous injection — abdomen, thigh, or upper arm |
| Supply | 4-week supply per order |
| Form | Pre-filled injection pen (3mL) |
| Active Ingredient | Semaglutide |
| Rx Required | Yes — provider review included |
 Pen&media=https://novametabolic.com/assets/images/product/69dfa72eb15961776265006.jpeg){kind=link}